يعرض 1 - 4 نتائج من 4 نتيجة بحث عن '"André van Maurik"', وقت الاستعلام: 2.43s تنقيح النتائج
  1. 1
    10 Years of belimumab experience: What have we learnt?

    المؤلفون: Bernie Rubin, Kerry Gairy, Tania Gonzalez-Rivera, David M. Roth, Roger A. Levy, Susan W Burriss, N.L. Fox, Munther Khamashta, André van Maurik, Angela Jones-Leone

    المصدر: Lupus

    مصطلحات موضوعية: Adult, medicine.medical_specialty, renal lupus, Lupus nephritis, Review, Disease, Antibodies, Monoclonal, Humanized, Food and drug administration, 03 medical and health sciences, 0302 clinical medicine, systemic lupus erythematosus, Rheumatology, Internal medicine, B-Cell Activating Factor, medicine, Humans, Immunologic Factors, Lupus Erythematosus, Systemic, 030212 general & internal medicine, Child, skin and connective tissue diseases, Randomized Controlled Trials as Topic, 030203 arthritis & rheumatology, business.industry, medicine.disease, Lupus Nephritis, Belimumab, Treatment Outcome, Tolerability, Musculoskeletal, Autoimmune inflammatory disease, Observational study, business, Standard therapy, Immunosuppressive Agents, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35583ea64309e0f1689c5edf3cb8290eTest
    https://doi.org/10.1177/09612033211028653Test


    أضف إلى المفضلة
  2. 2
    Target engagement and cellular fate of otelixizumab: a repeat dose escalation study of an anti‐CD3ε mAb in new‐onset type 1 diabetes mellitus patients

    المؤلفون: Ruth M Barnard, David Inman, Kevin R. Page, Bart Keymeulen, Quentin Leirens, Alexander MacDonald, Antonella Napolitano, Kim Brown, David Lanham, Jonathan Bullman, Minesh Patel, André van Maurik, Enrica Mezzalana, Caroline O. S. Savage, Georgios Vlasakakis, Stefano Zamuner

    المساهمون: Pathology/molecular and cellular medicine, Diabetes Pathology & Therapy, Diabetes Clinic

    المصدر: British Journal of Clinical Pharmacology. 85:704-714

    مصطلحات موضوعية: Adult, Male, Adolescent, CD3 Complex, type 1 diabetes, T-Lymphocytes, Receptors, Antigen, T-Cell, Pharmacology, Antibodies, Monoclonal, Humanized, 030226 pharmacology & pharmacy, Otelixizumab, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Pharmacokinetics, medicine, immunoinflammation, Humans, Pharmacology (medical), Molecular Targeted Therapy, 030212 general & internal medicine, Dosing, Infusions, Intravenous, PK/PD models, Type 1 diabetes, Dose-Response Relationship, Drug, target engagement, business.industry, T-cell receptor, PK/PD, Original Articles, medicine.disease, Clinical trial, Diabetes Mellitus, Type 1, Treatment Outcome, Pharmacodynamics, Female, dose–response, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0b3cc8aff306a4ae44c500abe35002d5Test
    https://doi.org/10.1111/bcp.13842Test


    أضف إلى المفضلة
  3. 3
    Anti‐IL‐7 receptor α monoclonal antibody (GSK2618960) in healthy subjects – a randomized, double‐blind, placebo‐controlled study

    المؤلفون: Simon M. McHugh, Paul W. Thompson, Frank A Gray, Onajite Kousin-Ezewu, Jenny L Craigen, Disala Fernando, Alasdair Coles, Donggang Su, Joanne Ellis, Keguan Chen, Sara Santos Franco, Joao-Joaquim Oliveira, Kim Brown, Lea Fortunato, André van Maurik, Ann M. Schwartz, Sophie Gisbert, Jiansong Yang, Sara Brett, Bill Davis, Joseph Cheriyan, Andrew Want, Jeffrey Price

    المصدر: British Journal of Clinical Pharmacology

    مصطلحات موضوعية: Adult, Male, drug safety, Adolescent, medicine.medical_treatment, T cell, T-Lymphocytes, Pharmacology, Antibodies, Monoclonal, Humanized, 030226 pharmacology & pharmacy, Autoimmune Diseases, immunology, Interleukin-7 Receptor alpha Subunit, Placebos, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Pharmacokinetics, Double-Blind Method, medicine, pharmacodynamics, Humans, Pharmacology (medical), 030212 general & internal medicine, Interleukin-7 receptor, Receptor, Infusions, Intravenous, Aged, biology, business.industry, Interleukin, Original Articles, Middle Aged, Healthy Volunteers, Cytokine, medicine.anatomical_structure, Pharmacodynamics, biology.protein, Original Article, Female, monoclonal antibodies, Antibody, business, pharmacokinetics, Half-Life

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af326e175e6773cbef32639a120f87e8Test
    http://europepmc.org/articles/PMC6339973Test


    أضف إلى المفضلة
  4. 4
    Autoantigen TRIM21/Ro52 is expressed on the surface of antigen-presenting cells and its enhanced expression in Sjögren’s syndrome is associated with B cell hyperactivity and type I interferon activity

    المؤلفون: Timothy R D J Radstake, Maarten R Hillen, André van Maurik, Sofie L M Blokland, Emma Koppe, Katia Urso, Joel A G van Roon, Aridaman Pandit, Tom Slocombe, Ana P Lopes

    المصدر: RMD Open
    RMD Open, Vol 6, Iss 2 (2020)

    مصطلحات موضوعية: autoantibodies, Immunology, lcsh:Medicine, Antigen-Presenting Cells, Inflammation, Autoimmunity, medicine.disease_cause, Autoantigens, type-I interferon, 03 medical and health sciences, 0302 clinical medicine, Immune system, stomatognathic system, Rheumatology, Interferon, medicine, Immunology and Allergy, Humans, 030212 general & internal medicine, Antigen-presenting cell, Sjøgren’s Syndrome, B cell, 030203 arthritis & rheumatology, B-Lymphocytes, biology, Sjögren Syndrome, business.industry, lcsh:R, Autoantibody, stomatognathic diseases, medicine.anatomical_structure, Sjogren's Syndrome, Ribonucleoproteins, Interferon Type I, biology.protein, medicine.symptom, Antibody, business, medicine.drug

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2beb14552fb0d53fd29f5ea6aa5fd431Test
    http://europepmc.org/articles/PMC7431915Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث